This segment focuses on the development, manufacturing, and commercialization of Olink's proprietary Proximity Extension Assay (PEA) kits. These kits enable researchers to quantify a large number of proteins simultaneously from small sample volumes. Research and development efforts are directed towards expanding the protein coverage of the kits, improving assay sensitivity and specificity, and developing new kits for specific research areas such as oncology, immunology, and neurology. The kits are used in a wide range of applications, including biomarker discovery, drug development, and personalized medicine. Olink's PEA technology offers a unique advantage in the proteomics field due to its high sensitivity, specificity, and multiplexing capabilities, allowing researchers to gain deeper insights into complex biological systems. Future opportunities include expanding the use of Olink kits in clinical diagnostics and developing automated solutions for high-throughput protein analysis.

This segment provides comprehensive proteomics services to researchers, including study design, sample preparation, assay execution, data processing, and bioinformatics analysis. Olink's service offerings cater to customers who prefer to outsource their proteomics experiments or require specialized expertise. Research and development activities are focused on optimizing workflows, improving data quality, and developing new bioinformatics tools for data analysis and interpretation. The services are used in a variety of applications, including biomarker validation, clinical trials, and drug target identification. Olink's service solutions provide researchers with access to cutting-edge proteomics technology and expertise, enabling them to accelerate their research and development efforts. Future opportunities include expanding the service offerings to include more specialized assays and developing cloud-based platforms for data sharing and collaboration.